Semglee

Five things to watch as the Biosimilars market heats up in 2022
Pharmaforum
Fri, 04/1/22 - 10:40 am
biosimilars
Humira
Semglee
innovations
ophthalmology
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Fierce Pharma
Fri, 01/21/22 - 11:00 am
Viatris
diabetes
Semglee
insulin
generics
Viatris launched two versions of its interchangeable insulin biosimilar. Why?
Fierce Pharma
Tue, 11/16/21 - 10:29 pm
Biocon
Viatris
Semglee
insulin
biosimilars
diabetes
Sanofi
Lantus
How This Historic FDA Approval Benefits Viatris
Motley Fool
Wed, 08/4/21 - 10:57 am
Viatris
Biocon
FDA
Semglee
biosimilars
insulin
diabetes
interchangeable biosimilars
FDA approves first interchangeable biosimilar
Biopharma Reporter
Thu, 07/29/21 - 11:19 am
FDA
biosimilars
interchangeable biosimilars
Semglee
Viatris
diabetes
insulin
Lantus
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Tue, 09/1/20 - 10:44 am
Biocon
Mylan
Semglee
generics
insulin
diabetes
biosimilars
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Motley Fool
Fri, 06/12/20 - 08:03 pm
FDA
Mylan
Biocon
Semglee
Sanofi
insulin
Lantus
diabetes